July 2025
The U.S. mRNA therapeutics market size was estimated at USD 5.48 billion in 2025 and is projected to hit USD 12.70 billion by 2036, with a notable CAGR of 8.77%
June 2026
The mRNA vaccines and therapeutics market size reached USD 116.88 billion in 2025 and is projected to surpass around USD 297.84 billion by 2035 with a CAGR of 9.81%.
May 2026
The mRNA therapeutics market size was valued at USD 20.83 billion in 2025 and is expected to hit around USD 45.40 billion by 2035, growing at a CAGR of 8.1%.
April 2026
The global mRNA therapeutics CDMO market size is estimated to hit around USD 14.63 billion by 2035 from USD 5.09 billion in 2025, with a CAGR of 11.14%.
January 2026
The U.S. mRNA synthesis raw materials market size is estimated to hit around USD 2,588.71 million by 2035 increasing from USD 682.25 million in 2025, with a CAGR of 14.26%.
January 2026
The U.S. digital therapeutics market size is exhibited at USD 3.72 billion in 2025 and is predicted to surpass USD 24.09 billion by 2035 with a remarkable CAGR of 20.54%.
August 2025
The global gene editing & mRNA tool kits market is driving advancements in gene therapy, synthetic biology, and molecular diagnostics worldwide
June 2026
The U.S. compounding pharmacies market size is valued at USD 6.45 billion in 2025 and is expected to hit around USD 11.52 billion by 2035, growing at a CAGR of 5.97%.
June 2026
The US peptide therapeutics market size was evaluated at USD 21.24 billion in 2025 and is predicted to hit around USD 34.98 billion by 2035, growing at a CAGR of 5.12%.
June 2026
The global brain health supplements and therapeutics market size accounted for USD 18.60 billion in 2025 and is predicted to hit around USD 47.37 billion by 2035, growing at a CAGR of 9.80%.
June 2026
The global alzheimer therapeutics market size is evaluated at USD 6.49 billion in 2025 and is predicted to hit around USD 38.61 billion by 2035, growing at a CAGR of 19.52%.
June 2026
The global rheumatology therapeutics market size is evaluated at USD 51.82 billion in 2025 and is predicted to hit around USD 68.49 billion by 2035, growing at a CAGR of 2.83%.
June 2026
The U.S. nutraceuticals market size was estimated at USD 179.83 billion in 2025 and is projected to surpass around USD 282.04 billion by 2035 with a CAGR of 4.6%.
June 2026
The U.S. multiple sclerosis drugs market size is estimated to hit around USD 18.43 billion by 2035 increasing from USD 8.44 billion in 2025, with a CAGR of 8.12%.
June 2026
The global plasma therapeutics market size is estimated to hit around USD 52.26 billion by 2035 increasing from USD 28.35 billion in 2025, with a CAGR of 6.31%.
June 2026
The global cancer therapeutics and biotherapeutics market size was valued at USD 210.73 billion in 2025 and is expected to hit around USD 475.26 billion by 2035, growing at a CAGR of 8.47%.
June 2026
The global U.S. biofuels market size was estimated at USD 50.07 billion in 2025 and is projected to hit around USD 96.51 billion by 2035, with a CAGR of 5.17%.
June 2026
The U.S. intra-abdominal pressure measurement devices market size was estimated at USD 71.26 billion in 2025 and is expected to hit around USD 158.82 billion by 2035, growing at a CAGR of 8.34%.
June 2026
The global natural killer (NK) cell therapeutics market size was evaluated at USD 477.10 million in 2025 and is predicted to hit around USD 12,316.96 million by 2035, growing at a CAGR of 38.42%.
June 2026
The global bacterial therapeutics market is growing as microbiome-based treatments gain traction in healthcare and biotechnology.
June 2026
The global psychedelic therapeutics market size is estimated to hit around USD 12.40 billion by 2035 increasing from USD 2.94 billion in 2025, with a CAGR of 15.48%.
June 2026
The U.S. patient engagement solutions market size surpass USD 7.40 billion in 2025 and is projected to cross around USD 27.83 billion by 2035 with a CAGR of 14.16%.
June 2026
The global bladder cancer therapeutics diagnostics market size was valued at USD 5.68 billion in 2025 and is expected to hit around USD 10.04 billion by 2035, growing at a CAGR of 5.86%.
June 2026
The global exosome therapeutics market size is evaluated at USD 928.93 thousand in 2025 and is predicted to hit around USD 4,564.32 thousand by 2035, with a CAGR of 17.26%.
June 2026
The global amyloidosis therapeutics market size was valued at USD 3.18 billion in 2025 and is expected to hit around 6.92 billion by 2035, growing at a CAGR of 8.09% from 2026 to 2035.
June 2026
The global peptide therapeutics CDMO market is growing as pharma and biotech companies outsource complex peptide drug development and manufacturing.
June 2026
The U.S. vehicle-to-grid technology market size is evaluated at USD 1.85 billion in 2025 and is projected to surpass around USD 25.43 billion by 2035 with a solid CAGR of 33.80%.
June 2026
The U.S. DNA nanotechnology market size is accounted to hit around USD 18.03 billion by 2035 increasing from USD 2.01 billion in 2025, with a CAGR of 24.53%.
June 2026
The U.S. concierge medicine market size is valued at USD 6.55 billion in 2025 and is projected to be worth around USD 12.75 billion by 2035 with CAGR of 6.88%.
June 2026
The U.S. revenue cycle management market size was valued at USD 65.43 billion in 2025 and is predicted to hit around USD 191.67 billion by 2035, at a CAGR of 11.50%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com